Streetbeat News

Marketing

PROC

Procaps Group's new CEO, Jose Vieira, issued a letter to shareholders outlining his immediate focus on strengthening the company's financial position and cash management. He emphasized a commitment to transparency, innovation, and collaboration, aiming for consistent growth and profitability. Vieira plans to implement immediate actions to improve the financial situation in the short term and is developing a clear strategy for sustainable growth.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:53 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX), also known as MangoRx, is launching 'PRIME', an oral testosterone replacement therapy powered by Kyzatrex. The Dallas-based telemedicine company is offering 2 months of free 'PRIME' to the first 1,000 male subscribers. This promotion is part of a broader marketing strategy, including a marquee sponsorship with Barstool Sports. PRIME is one of only three FDA-approved oral TRT treatments, promising enhanced vitality, mood, cognition, and physical performance. It will be priced at $199/month, with a 10% discount for subscribers of other MangoRx products.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:52 pm

MCD

McDonald's Corporation (NYSE:MCD) reported mixed Q4 2023 results with adjusted EPS of $2.95, beating consensus but sales of $6.41 billion fell short. U.S. same-store sales rose 4.3%, with worldwide growth at 3.4%. International sales were impacted by Middle East tensions, particularly in the developmental licensed markets segment. The company's loyalty program and digital growth contributed positively, while charges related to software write-offs and restructuring impacted operating income.

Portfolio Pulse from Vandana Singh

February 05, 2024 | 1:29 pm

TWST

Twist Bioscience Corporation (NASDAQ:TWST) announced the early access of its Twist Flex Prep Ultra High-Throughput (UHT) Kit, designed to significantly reduce costs and increase efficiency in NGS workflows, particularly in agricultural genomics. The kit features novel Normalization By Ligation (NBL) technology for self-normalizing sample inputs, enhanced multiplexing capabilities, and compatibility with automation systems. This innovation is expected to accelerate NGS adoption in AgBio by offering a scalable, streamlined, and cost-effective solution. Twist Bioscience will showcase this technology at the AGBT General Meeting in Orlando, FL.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:24 pm

PPG

PPG Industries and Tasca Racing have extended their partnership, with the PPG FORD DARK HORSE NITRO MUSTANG Funny Car set to appear in four events this year. This collaboration highlights the ongoing relationship between PPG and Tasca Racing, emphasizing PPG's commitment to the automotive racing industry.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:13 pm

JSPR

Jasper Therapeutics announced its participation in the American Academy of Allergy, Asthma, and Immunology Annual Meeting with presentations on preclinical data for Briquilimab, an Anti-CD117 antibody. The data shows Briquilimab's potential in preventing systemic anaphylaxis, allergic asthma, and anaphylactoid drug reactions in mice models. The presentations are scheduled for February 23-25, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:11 pm

VRCA

Verrica Pharmaceuticals has initiated legal action against a Canadian drug manufacturer, accusing them of false advertising and unfair competition in the U.S. market. The lawsuit centers on the sale of unapproved drugs containing cantharidin, which directly competes with Verrica's offerings.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 12:39 pm

META

Meta's Oversight Board has criticized the company's current deepfake rules as 'incoherent' after reviewing a controversial video of President Joe Biden. The board suggests extending the manipulated media policy to cover all audio and video content, not just AI-generated material. Meta plans to update its policy to adapt to the evolving AI landscape. This comes amid growing concerns over deepfake content and its potential misuse, with Meta committed to advancing AI technology.

Portfolio Pulse from Benzinga Neuro

February 05, 2024 | 12:21 pm

TSLA

Tesla Inc. (NASDAQ:TSLA) has announced the return of Full Self-Driving (FSD) beta transfers for recent vehicle buyers and extended the lifetime Supercharging benefit to include Model 3. This decision follows customer feedback and earlier speculation, with the FSD beta transfer now available for Model S, X, 3, or Y purchases in North America before the end of March. Additionally, the free lifetime Supercharging offer, previously exclusive to Model S, X, and Y, is now extended to Model 3 buyers taking delivery by March 31.

Portfolio Pulse from Benzinga Neuro

February 05, 2024 | 7:31 am

AAPL

MOMO

Hello Group Inc. (NASDAQ:MOMO) has launched inSpaze, a native immersive social app for Apple Vision Pro in the U.S. The app, designed for visionOS, offers 3D interaction, Spatial Audio, and social features like real-time translation and social games. It's available for Apple Vision Pro users and can also be used on iPhone via the App Store.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 7:20 am